Calidi Readies SPAC Merger

BIOTECH: Estimated Proceeds Up to $82M

■ By JEFF CLEMETSON
FRONT PAGE

Calidi Biotherapeutics, Inc. will soon be getting a ticker on the NYSE. The company is currently preparing for a merger with special purpose acquisition company First Light Acquisition Group (FLAG) and expects to be trading on the NYSE American...

Read latest San Diego Business Journal online.

Online newspapers at PressDisplay.